中国当代医药
中國噹代醫藥
중국당대의약
PERSON
2015年
1期
79-81
,共3页
子宫内膜异位症%孕三烯酮%米非司酮
子宮內膜異位癥%孕三烯酮%米非司酮
자궁내막이위증%잉삼희동%미비사동
Endometriosis%Gestrinone%Mifepristone
目的:探讨子宫内膜异位症术后应用米非司酮和孕三烯酮的治疗效果。方法将120例盆腔子宫内膜异位症手术患者,按照住院顺序编号,单号为孕三烯酮组,2.5 mg/次,2次/周,口服给药。双号为米非司酮组,给予12.5 mg/次,1次/d,口服给药。对比分析两组的治疗效果。结果米非司酮组的治疗效果明显优于孕三烯酮组,差异有统计学意义(孕<0.05);两组治疗后的血清P水平较治疗前明显下降,差异有统计学意义(孕<0.05)。两组患者治疗前后的FSH、LH、E2、PRL水平无明显变化,差异无统计学意义(孕>0.05);米非司酮组和孕三烯酮组出现恶心症状的患者分别有8例(13.33%)和25例(41.67%),差异有统计学意义(孕<0.05)。结论子宫内膜异位症术后使用米非司酮的治疗效果较孕三烯酮好。
目的:探討子宮內膜異位癥術後應用米非司酮和孕三烯酮的治療效果。方法將120例盆腔子宮內膜異位癥手術患者,按照住院順序編號,單號為孕三烯酮組,2.5 mg/次,2次/週,口服給藥。雙號為米非司酮組,給予12.5 mg/次,1次/d,口服給藥。對比分析兩組的治療效果。結果米非司酮組的治療效果明顯優于孕三烯酮組,差異有統計學意義(孕<0.05);兩組治療後的血清P水平較治療前明顯下降,差異有統計學意義(孕<0.05)。兩組患者治療前後的FSH、LH、E2、PRL水平無明顯變化,差異無統計學意義(孕>0.05);米非司酮組和孕三烯酮組齣現噁心癥狀的患者分彆有8例(13.33%)和25例(41.67%),差異有統計學意義(孕<0.05)。結論子宮內膜異位癥術後使用米非司酮的治療效果較孕三烯酮好。
목적:탐토자궁내막이위증술후응용미비사동화잉삼희동적치료효과。방법장120례분강자궁내막이위증수술환자,안조주원순서편호,단호위잉삼희동조,2.5 mg/차,2차/주,구복급약。쌍호위미비사동조,급여12.5 mg/차,1차/d,구복급약。대비분석량조적치료효과。결과미비사동조적치료효과명현우우잉삼희동조,차이유통계학의의(잉<0.05);량조치료후적혈청P수평교치료전명현하강,차이유통계학의의(잉<0.05)。량조환자치료전후적FSH、LH、E2、PRL수평무명현변화,차이무통계학의의(잉>0.05);미비사동조화잉삼희동조출현악심증상적환자분별유8례(13.33%)화25례(41.67%),차이유통계학의의(잉<0.05)。결론자궁내막이위증술후사용미비사동적치료효과교잉삼희동호。
Objective To investigate the treatment effect of mifepristone and gestrinone applied after surgery of en-dometriosis. Methods 120 cases with pelvic endometriosis were numbered according to hospitalization sequence,odd numbers were the gestrinone group,2.5 mg every time, twice a week,oral administration,while even numbers were the mifepristone group,and the patients were given oral mifepristone 12.5 mg every time, once a day.The treatment effect of both groups were compared and analyzed. Results The treatment effect of the mifepristone group was obviously better than that of the gestrinone group,the difference was statistically significant (P<0.05);The serum level of P in both groups were significantly lower than that before treatment,the difference was statistically significant (P<0.05).The serum level of FSH,LH,E2,PRL in both groups were no significant difference (P>0.05).Nausea symptom of the mifepristone group were 8 cases (13.33%) and the gestrinone group were 25 cases (41.67%),the difference was statistically significant (P<0.05). Conclusion The postoperative application of mifepristone to treating endometriosis can gain better effect than gestri-none.